General
Rulemaking: Comments on Research Involving Human Fetal Tissue (February 2021)
Comments on Research Involving Human Fetal Tissue (February 2021)
The United States Conference of Catholic Bishops (USCCB) submitted comments supporting a proposed U.S. Department of Health and Human Services (HHS) rule that would strengthen safeguards and oversight for federally funded research involving human fetal tissue, particularly tissue obtained from abortions.
The USCCB strongly supports the proposed HHS rule as a step toward greater ethical oversight of fetal tissue research but argues that the federal government should go further by reducing dependence on abortion-derived fetal tissue and promoting alternative research methods.
Human dignity and research ethics: The USCCB argues that unborn children are human subjects deserving protection and respect in medical research. It cites the Nuremberg Code, federal research ethics regulations, and historical abuses in medical research as evidence for strong protections.
Federal law supports stronger safeguards
The letter reviews several federal statutes that:
- Protect fetuses and newborns involved in research.
- Require separation between abortion decisions and tissue donation decisions.
- Prohibit the sale of fetal tissue for valuable consideration.
- Seek to prevent financial incentives from influencing abortion or tissue procurement.
Support for the proposed rule
The USCCB endorses the proposal’s efforts to:
- Reduce conflicts of interest.
- Prevent abortion decisions from being influenced by tissue donation opportunities.
- Exclude for-profit entities from certain fetal tissue procurement activities.
- Strengthen ethical oversight of federally funded research.
While welcoming the proposal, the USCCB argues that procedural safeguards alone cannot completely separate fetal tissue research from the ethical concerns surrounding abortion. It contends that:
- Availability of tissue donation may influence some abortion decisions.
- Public promotion of medical benefits from fetal tissue research could indirectly encourage abortion.
- Parents who have chosen abortion may not be in the same position as other parents when providing consent regarding a child's remains.
Discussion of Vaccines
The letter uses COVID-19 vaccines as an example:
- The USCCB opposes the use of abortion-derived fetal tissue in research and vaccine development.
- However, it acknowledges that individuals may ethically receive vaccines connected to historic fetal cell lines when no alternative is available and serious health risks exist.
- The organization argues that reliance on abortion-derived cell lines has contributed to public concerns and vaccine hesitancy among some people.
The USCCB recommends that the final rule:
- Reference the full range of federal statutes governing fetal research and fetal tissue use.
- Prohibit abortion facilities from advertising tissue donation opportunities.
- Discourage or prohibit federal funding for the creation of new cell lines derived from fetal tissue obtained from abortions.
- Encourage development of alternative research methods that do not rely on fetal tissue from abortions.
Comments_on_Research_Involving_Human_Fetal_Tissue_February_2021.pdf